Tender offer vs. direct sale: what's the difference in private markets?

A simple definition

A tender offer is a structured process in which shareholders are invited to sell some or all of their shares under a defined set of terms: one price, one window, one set of rules for everyone eligible. In private markets, tender offers are typically organized by the company itself or by a major investor seeking to buy a meaningful position. The company-led version has become a standard feature of late-stage startup life: rather than rushing to a potential exit, such as an IPO, companies periodically open a liquidity window so employees and early holders can sell a portion of their stock.

How tender offers are typically run

The defining feature is standardization. The organizer sets a fixed price per share, often informed by a recent funding round or a third-party valuation, and a fixed timeline. Under U.S. tender offer rules, the offer generally must remain open for at least 20 business days.

Eligibility rules and participation limits do a lot of work here. A company might restrict participation to current employees with fully vested shares, or cap each seller at 20% of their holdings, or exclude executives entirely. These limits exist for reasons that have little to do with any individual seller: managing the cap table, controlling dilution of insider ownership, and limiting how much stock changes hands at once.

Communication runs through the company. Sellers receive offer documents, disclosures, and a deadline. The company handles approvals, coordinates with its transfer agent, and settles the transaction. For the individual shareholder, the process is closer to filling out paperwork than negotiating a deal.

A simple definition

A direct sale is a negotiated transaction between a seller and a buyer: no company-organized window, no uniform terms. A shareholder finds a buyer (or a buyer finds them), they agree on a price, and they work through the company's transfer requirements to close. Terms can vary widely depending on the counterparty, the company's transfer policies, and timing.

How direct sales usually work

The first task is finding the other side. That might happen through personal networks, a broker, or a private marketplace that connects sellers of pre-IPO shares with accredited buyers. Then comes price negotiation, which in private markets is wide open. There's no ticker to anchor on, so the price reflects what this buyer will pay this seller for this block, informed by recent rounds, secondary market activity, and how badly each side wants the deal.

Documentation follows: a stock transfer agreement, company consent, and often a right of first refusal (ROFR) process, where the company or its designated investors get the chance to buy the shares at the agreed price before the outside buyer can. ROFR periods commonly run 30 days or more, and the company can also simply decline to approve the transfer, depending on its bylaws and the shareholder's agreements.

Some direct secondary transactions don't transfer shares directly at all. A buyer may participate through a platform that handles structuring, diligence, and settlement, or through a special purpose vehicle (SPV): a single-purpose entity that holds the shares while investors own interests in the entity. This is common when multiple buyers pool into one block, or when the company prefers a single entry on its cap table.

Price discovery and control

A tender offer sets one price for all participants, decided before the window opens. That's efficient and equitable, but it means no individual seller can negotiate. If you think the offer price undervalues the company, your only move is to not participate.

Direct sales work the other way. Price is discovered through negotiation, deal by deal. A motivated buyer might pay above the last round's valuation; a seller who needs liquidity quickly might accept a discount. The seller has more control — and more exposure to their own negotiating position.

Speed, process, and certainty

Tender offers trade flexibility for predictability. The timeline is published, the paperwork is standardized, the approvals are pre-arranged, and the company wants the process to close. Once you tender your shares, execution risk is low.

A direct sale can move quickly if the buyer is ready and the company cooperates, but each step — negotiation, documentation, ROFR, board or transfer-agent approval — is a place where the deal can slow down or fall apart. Flexibility is the draw; certainty is the cost.

Access for sellers and buyers

Tender offers restrict who can participate on both sides. Sellers must meet the eligibility rules; the buyer is usually pre-selected (the company itself or an anchor investor). An outside investor generally can't buy into someone else's tender offer.

Direct sales open access more selectively. Any shareholder with transferable stock can, in principle, seek a buyer, and any accredited investor can, in principle, seek shares. In practice, access depends on structure: direct one-to-one transfers require finding each other and clearing company approval, while marketplaces and SPV platforms widen the pool by handling sourcing and structure. For investors trying to build positions in pre-IPO companies, direct secondaries are usually the only path in, since tender offers rarely admit new outside buyers.

In practice, the tender offer vs. direct sale decision depends less on preference than on circumstance: what the company allows, what the shareholder needs, and what's available right now.

When a tender offer makes more sense

Tender offers suit liquidity at scale. The classic case is the employee liquidity program: a late-stage company with hundreds of long-tenured employees runs an annual or semi-annual tender so people can sell without each transaction becoming its own negotiation. Tender offers also work for shareholder clean-up, consolidating dozens of small early holders into one institutional position, and for any broad, coordinated liquidity event where the company wants uniform pricing and a controlled process.

When a direct sale makes more sense

Direct sales fit one-off needs. An early employee with a house to buy can't wait for the company to schedule a tender. An investor with conviction about one specific company wants a targeted secondary transaction, not whatever happens to be tendering this quarter. And some deals need custom structure that a standardized tender process can't accommodate: a forward agreement, an SPV with specific terms, a block trade with staged settlement.

Neither side of the tender offer vs. direct sale comparison eliminates the underlying risks of private market investing: illiquidity, limited disclosure, and valuations that may not reflect what shares would fetch in an open market. But each structure carries its own friction.

Risks in tender offers

The structure that makes tender offers predictable also makes them rigid. Sellers can't negotiate price or timing. Participation caps may mean you can only sell a fraction of what you'd like. And the offer price is set by the organizer, typically with reference to a recent round or third-party valuation. Sellers should understand how the price was determined and whether it includes a discount to the company's preferred-stock valuation, as common shares often do.

Risks in direct sales

Direct sales concentrate risk in the process itself. Timelines stretch: negotiation, documentation, ROFR windows, and company approvals can take months, and the company may decline the transfer altogether. Settlement adds its own complexity: verifying the shares, confirming transfer restrictions, coordinating payment against delivery. That last mile is where inexperienced buyers and sellers most often run into trouble. Working through an established platform or qualified intermediary doesn't remove these risks, but it puts the documentation and approval mechanics in experienced hands.

Augment provides structured workflows for private secondary transactions, connecting sellers of pre-IPO shares with accredited investors through a marketplace built for this asset class. That includes support for SPV structures, company approval processes, and share transfer mechanics, with the goal of giving both sides more visibility into pricing, timing, and execution status than a one-off negotiated deal typically offers.

For investors, Augment's pre-IPO investment platform is designed to reduce the friction that has historically kept individual accredited investors out of direct secondaries: sourcing, diligence materials, structuring, and settlement coordination in one place. For sellers, it means reaching qualified buyers without running the search alone.

The tender offer vs. direct sale distinction comes down to who controls the transaction. Tender offers centralize control with the company in exchange for standardized pricing and a predictable process. Direct sales hand control to the individual shareholder in exchange for longer timelines and more moving parts. Companies reach for tenders when they need to deliver liquidity broadly; shareholders and investors reach for direct sales when the need is specific — one block, one buyer, one timeline.

For anyone weighing tender offer vs. direct sale, the homework is the same: understand how the price was set, what approvals stand between agreement and settlement, and what rights the company retains over your shares. The structure you choose shapes all of it.

Augment's role is to make the direct path more workable for sellers who can't wait for a tender window, and for investors who don't want to.